Clever Leaves Holdings Inc. (CLVR): Price and Financial Metrics

Clever Leaves Holdings Inc. (CLVR): $1.04

-0.04 (-3.70%)

POWR Rating

Component Grades













Add CLVR to Watchlist
Sign Up

Industry: Agriculture



in industry


  • CLVR scores best on the Growth dimension, with a Growth rank ahead of 61.53% of US stocks.
  • The strongest trend for CLVR is in Growth, which has been heading down over the past 179 days.
  • CLVR ranks lowest in Quality; there it ranks in the 4th percentile.

CLVR Stock Summary

  • Clever Leaves Holdings Inc's market capitalization of $80,727,944 is ahead of only 13.16% of US-listed equities.
  • Clever Leaves Holdings Inc's stock had its IPO on December 11, 2018, making it an older stock than merely 10.44% of US equities in our set.
  • In terms of volatility of its share price, CLVR is more volatile than 98.68% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Clever Leaves Holdings Inc, a group of peers worth examining would be ISUN, CREX, OSW, OEG, and TRKA.
  • CLVR's SEC filings can be seen here. And to visit Clever Leaves Holdings Inc's official web site, go to

CLVR Valuation Summary

  • CLVR's price/sales ratio is 16.8; this is 342.11% higher than that of the median Healthcare stock.
  • Over the past 33 months, CLVR's EV/EBIT ratio has gone NA NA.
  • Over the past 33 months, CLVR's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for CLVR.

Stock Date P/S P/B P/E EV/EBIT
CLVR 2021-08-31 16.8 3.1 -7.7 -8.2
CLVR 2021-08-30 17.2 3.1 -7.9 -8.4
CLVR 2021-08-27 17.9 3.3 -8.2 -8.8
CLVR 2021-08-26 17.7 3.2 -8.1 -8.6
CLVR 2021-08-25 18.0 3.3 -8.3 -8.8
CLVR 2021-08-24 18.9 3.4 -8.7 -9.3

CLVR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CLVR has a Quality Grade of D, ranking ahead of 7.67% of graded US stocks.
  • CLVR's asset turnover comes in at 0.095 -- ranking 266th of 681 Pharmaceutical Products stocks.
  • 500 - Internal server error

The table below shows CLVR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.095 0.618 -0.384
2021-03-31 0.073 0.612 -0.199
2020-12-31 0.086 0.612 -0.185
2020-12-31 0.086 0.612 -0.277
2020-09-30 0.029 0.529 -0.026
2020-09-30 0.000 NA 0.001

CLVR Price Target

For more insight on analysts targets of CLVR, see our CLVR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $12.00 Average Broker Recommendation 1.5 (Moderate Buy)

CLVR Stock Price Chart Interactive Chart >

Price chart for CLVR

CLVR Price/Volume Stats

Current price $1.04 52-week high $12.40
Prev. close $1.08 52-week low $0.91
Day low $1.01 Volume 333,606
Day high $1.06 Avg. volume 5,464,890
50-day MA $1.57 Dividend yield N/A
200-day MA $4.34 Market Cap 31.33M

Clever Leaves Holdings Inc. (CLVR) Company Bio

Clever Leaves Holdings, Inc. operates as a holding company. It produces pharmaceutical-grade cannabinoids. The company was founded on July 23, 2020 and is headquartered in New York, NY.

CLVR Latest News Stream

Event/Time News Detail
Loading, please wait...

CLVR Latest Social Stream

Loading social stream, please wait...

View Full CLVR Social Stream

Latest CLVR News From Around the Web

Below are the latest news stories about Clever Leaves Holdings Inc that investors may wish to consider to help them evaluate CLVR as an investment opportunity.

Clever Leaves Expands Partnership With Cansativa; Cansativa Raises Up to $15 Million in Financing Led by Casa Verde

Clever Leaves enters three-year commercial supply agreement with German distributor and wholesaler to enhance access into medicinal cannabis marketBOCA RATON, Fla. and FRANKFURT, Germany, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today announced the expansion of its partnership with German cannabis distributor and wholesaler Ca

Yahoo | February 22, 2022

Clever Leaves'' Pharmaceutical-Grade Cannabis Extracts Reach Germany Via Ethypharm Partnership | Benzinga

Pharmaceutical-grade cannabinoids extracts produced by Clever Leaves Holdings Inc. (NASDAQ:

Benzinga | February 17, 2022

Clever Leaves'' Pharmaceutical-Grade Cannabis Extracts Reach Germany Via Ethypharm Partnership

Pharmaceutical-grade cannabinoids extracts produced by Clever Leaves Holdings Inc. (NASDAQ: CLVR ) will soon be available for distribution by its partner in Germany , Ethypharm GmbH , a European specialty pharmaceutical company. Following a March 2021 supply agreement signed by the two companies providing Ethypharm access to Clever Leaves Holdings EU GMP certified cannabis extracts , the shipment includes two products: a 100 mg CBD with 3 mg THC per gram formulation and a 200 mg CBD with 6 mg THC per gram formulation . “As the largest medical cannabis market in Europe and one of the most … Full story available on

Benzinga | February 17, 2022

Clever Leaves Holdings Begins Sales of Cannabis Extracts in Germany Through Ethypharm Partnership

Products imported and to be commercially available in German pharmacies Products imported and to be commercially available in German pharmacies

GlobeNewswire | February 17, 2022

Cannabis Movers & Shakers: Ascend Wellness, MedMen, Clever Leaves, Palo Santo, GoldCann

Ascend Wellness Promotes Frank Perullo To President Ascend Wellness Holdings, Inc. (CSE: AAWH.U) (OTCQX: AAWH ) has promoted its co-founder and chief strategy officer, Frank Perullo, to president. At his new position, Perullo will be responsible for AWH''s day-to-day operations with the retail, sales and marketing as well as operations departments will report directly to Perullo going forward, in addition to his existing reports, the company said Monday. Abner Kurtin, founder and CEO of AWH will continue to lead the company and oversee Perullo, along with Dan Neville, chief financial officer, and Robin Debiase, chief people officer. “I can''t think of a better person to step into the President role than Frank, as we further develop our canopy, brand portfolio, and retail footprint in 20...

Benzinga | February 14, 2022

Read More 'CLVR' Stories Here

CLVR Price Returns

1-mo -34.59%
3-mo -8.77%
6-mo N/A
1-year -88.52%
3-year N/A
5-year N/A
YTD -66.45%
2021 -65.17%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9329 seconds.